Anne F. Luetkemeyer
University of California, San Francisco(US)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Tuberculosis Research and Epidemiology, Hepatitis B Virus Studies, COVID-19 Clinical Research Studies
Most-Cited Works
- → Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19(2020)1,899 cited
- → Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis(2011)538 cited
- → Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1(2015)465 cited
- → Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1(2015)420 cited
- → Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections(2023)398 cited
- → Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy(2016)362 cited
- → Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection(2014)254 cited
- → Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study(2017)156 cited
- → Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study(2018)144 cited
- → Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections(2019)131 cited